Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Experimental & Clinical Cancer Research
Published in: Journal of Experimental & Clinical Cancer Research 1/2008

Open Access 01-05-2008 | Editorial

A new era for Journal of Experimental & Clinical Cancer Research

Author: Mauro Castelli

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2008

Login to get access

Excerpt

Journal of Experimental & Clinical Cancer Research (JECCR), the official journal of the "Regina Elena" National Cancer Institute [1] of Rome, has moved to BioMed Central's open access publishing platform. Overseen by the Editor-in-Chief Mauro Castelli and supported by an international Editorial Board [2], the journal aims to provide a high-quality forum for basic and translational work in oncology. …
Literature
1.
2.
3.
4.
Schünemann HJ, Castelli M, Muti P: Systematic Reviews for the Journal of Experimental & Clinical Cancer Research: Going where the Science takes us. J Exp & Clin Cancer Res. 2007, 169-174.
5.
Metadata
Title
A new era for Journal of Experimental & Clinical Cancer Research
Author
Mauro Castelli
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2008
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/1756-9966-27-1

Other articles of this Issue 1/2008

Journal of Experimental & Clinical Cancer Research 1/2008 Go to the issue

Erratum

Erratum to: Dark Aberrant Crypt Foci with activated Wnt pathway are related to tumorigenesis in the colon of AOM-treated rat

Research

Antitumor efficacy of combination of interferon-gamma-inducible protein 10 gene with gemcitabine, a study in murine model

Research

Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy

Research

Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells

Review

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

Review

Chinese herb related molecules of cancer-cell-apoptosis: a minireview of progress between Kanglaite injection and related genes
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits